Bacillus subtilis
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Bacillus subtilis
- DrugBank Accession Number
- DB11347
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Bacillus subtilis whole
- Vibrio subtilis whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Bactisporin
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Biovita Bacillus subtilis (3 mg/1g) + Ascorbic acid (5 mg/1g) + Calcium phosphate dihydrate (20 mg/1g) + Nicotinamide (0.1 mg/1g) + Riboflavin (0.2 mg/1g) + Thiamine mononitrate (0.3 mg/1g) Granule Oral Ildong Pharmaceutical Co., Ltd. 2015-06-03 2019-09-13 US Biovita Bacillus subtilis (3 mg/1g) + Ascorbic acid (5 mg/1g) + Calcium phosphate dihydrate (20 mg/1g) + Nicotinamide (0.1 mg/1g) + Riboflavin (0.2 mg/1g) + Thiamine mononitrate (0.3 mg/1g) Granule Oral OASIS TRADING 2018-12-25 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Biovita Bacillus subtilis (3 mg/1g) + Ascorbic acid (5 mg/1g) + Calcium phosphate dihydrate (20 mg/1g) + Nicotinamide (0.1 mg/1g) + Riboflavin (0.2 mg/1g) + Thiamine mononitrate (0.3 mg/1g) Granule Oral Ildong Pharmaceutical Co., Ltd. 2015-06-03 2019-09-13 US Biovita Bacillus subtilis (3 mg/1g) + Ascorbic acid (5 mg/1g) + Calcium phosphate dihydrate (20 mg/1g) + Nicotinamide (0.1 mg/1g) + Riboflavin (0.2 mg/1g) + Thiamine mononitrate (0.3 mg/1g) Granule Oral OASIS TRADING 2018-12-25 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8CF93KW41W
- CAS number
- 68038-70-0
References
- General References
- Not Available
- External Links
- 1311119
- Wikipedia
- Bacillus_subtilis
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Unknown Status Treatment Gut Microbiota / Irritable Bowel Syndrome (IBS) 1 3 Not Yet Recruiting Supportive Care Amyloidosis, Immunoglobulin Light-chain 1 Not Available Completed Basic Science Coronavirus Disease 2019 (COVID‑19) / COVID-19 Pneumonia 2 Not Available Completed Treatment Coronavirus Disease 2019 (COVID‑19) / Flu caused by Influenza 1 Not Available Completed Treatment Coronavirus Disease 2019 (COVID‑19) / Rhinitis / Rhino Sinusitis 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Granule Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 03, 2015 16:52 / Updated at September 28, 2021 21:54